COLL FY 2025 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$781M+23.6% YoY

Gross Profit

$463M59.3% margin

Operating Income

$187M24.0% margin

Net Income

$63M8.1% margin

EPS (Diluted)

$1.73

Cash Flow

Operating Cash Flow

$329M

Free Cash Flow

$328M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.4B

Stockholders' Equity

$302M

Cash & Equivalents

$251M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$781M	$631M	+23.6%
Gross Profit	$463M	$377M	+22.8%
Operating Income	$187M	$170M	+10.1%
Net Income	$63M	$69M	-9.1%